/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

DBV Technologies S.A. - Spons-ADR Share Price Today: Live Updates & Key Insights

DBV Technologies S.A. - Spons-ADR share price today is $13.73, up -1.66%. The stock opened at $13.53 against the previous close of $13.86, with an intraday high of $13.76 and low of $13.39.

DBV Technologies S.A. - Spons-ADR Share Price Chart

style
pb-0

DBV Technologies S.A. - Spons-ADR

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

DBV Technologies S.A. - Spons-ADR Share Price Performance

$13.73 -0.0166(-1.66%) DBVT at 27 Jul 2026 02:37 PM Biotechnology
Lowest Today 13.39
Highest Today 13.76
Today’s Open 13.53
Prev. Close 13.86
52 Week High 26.19
52 Week Low 8.51
Day’s Range: Low 13.39 High 13.76
52-Week Range: Low 8.51 High 26.19
1 day return -
1 Week return -6.04
1 month return -15.61
3 month return -32.95
6 month return -40.25
1 year return +35.74
3 year return +321.91
5 year return +31.69
10 year return -

DBV Technologies S.A. - Spons-ADR Institutional Holdings

MPM Oncology Impact Management LP 8.81

Vivo Capital, LLC 4.51

Artisan Partners Limited Partnership 3.75

Siren, L.L.C. 3.14

Baker Bros Advisors LP 2.47

ADAR1 Capital Management LLC 1.71

Perceptive Advisors LLC 1.63

Artisan International Small-Mid Investor 1.42

Artisan Non-U.S. Small-Mid Growth Comp 1.42

Patient Square Capital LP 1.17

Octagon Capital Advisors LP 0.97

Ikarian Capital, LLC 0.89

Redmile Group, LLC 0.83

Duquesne Family Office LLC 0.65

Millennium Management LLC 0.54

Atika Capital Management LLC 0.46

Elmind Capital LP 0.45

Balyasny Asset Management LLC 0.39

Ameriprise Financial Inc 0.39

Yiheng Capital LLC 0.29

New York State Common Retirement Fund 0.28

BOOTHBAY FUND MANAGEMENT, LLC 0.28

DWS ESG Biotech LC 0.10

AdvisorShares Dorsey Wright ADR ETF 0.07

Russell Inv US Small Cap Equity Y 0.04

Dorsey Wright Sys Reltv Strength Intl 0.03

Russell Investment Small Cap Fund F 0.03

Artisan International Small-Mid Tr Fdrs 0.02

Fidelity Nasdaq Composite Index 0.02

Russell Inv US Small Cap Equity 0.01

Russell Investment Equity II 0.01

ActivePassive International Equity ETF 0.01

Steward Values Enhanced International I 0.01

Lord Abbett Health Care R6 0.01

Lord Abbett Global Hlth Cr IF GBP Acc 0.00

Gabelli Health & Wellness 0.00

ST Dorsey Wright® Intl Momntm Tr 39 CA 0.00

ST Dorsey Wright® Intl Momntm Tr 42 CA 0.00

HJIM International Select Small Cap 0.00

DBV Technologies S.A. - Spons-ADR Market Status

Strong Buy: 0

Buy: 2

Hold: 0

Sell: 1

Strong Sell: 0

DBV Technologies S.A. - Spons-ADR Fundamentals

Market Cap 820.28 M

PB Ratio 5.0259

PE Ratio 0.0

Enterprise Value 660.86 M

Total Assets 233.72 M

Volume 190911

DBV Technologies S.A. - Spons-ADR Company Financials

Annual Revenue FY23:0 0.0M, FY22:4800000 4.8M, FY21:5708000 5.7M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:4800000 4.8M, FY21:5708000 5.7M, FY20:null 0.0M, FY19:-144983000 -145.0M

Annual Net worth FY23:-100781000 -100.8M, FY22:-96300000 -96.3M, FY21:-97809000 -97.8M, FY20:-159559000 -159.6M, FY19:-172042746 -172.0M

Quarterly Revenue Q2/2026:0 0.0M, Q1/2026:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:511000 0.5M

Quarterly Profit Q2/2026:null 0.0M, Q1/2026:-4215266 -4.2M, Q3/2025:-4281868 -4.3M, Q2/2025:-4619486 -4.6M, Q1/2025:-4477344 -4.5M

Quarterly Net worth Q2/2026:-50400000 -50.4M, Q1/2026:-47600000 -47.6M, Q3/2025:-33016481 -33.0M, Q2/2025:-42402674 -42.4M, Q1/2025:-27099244 -27.1M

About DBV Technologies S.A. - Spons-ADR & investment objective

Company Information DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.

Organisation Biotechnology

Employees 170

Industry Biotechnology

CEO Mr. Daniel Tassé

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

DBV Technologies S.A. - Spons-ADR FAQs

What is the share price of DBV Technologies S.A. - Spons-ADR today?

The current share price of DBV Technologies S.A. - Spons-ADR is $13.73.

Can I buy DBV Technologies S.A. - Spons-ADR shares in India?

Yes, Indian investors can buy DBV Technologies S.A. - Spons-ADR shares by opening an international trading and demat account with Motilal Oswal.

How to buy DBV Technologies S.A. - Spons-ADR shares in India?

You can easily invest in DBV Technologies S.A. - Spons-ADR shares from India by:

Can I buy fractional shares of DBV Technologies S.A. - Spons-ADR?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of DBV Technologies S.A. - Spons-ADR?

DBV Technologies S.A. - Spons-ADR has a market cap of $820.28 M.

In which sector does DBV Technologies S.A. - Spons-ADR belong?

DBV Technologies S.A. - Spons-ADR operates in the Biotechnology sector.

What documents are required to invest in DBV Technologies S.A. - Spons-ADR stocks?

To invest, you typically need:

What is the PE and PB ratio of DBV Technologies S.A. - Spons-ADR?

The PE ratio of DBV Technologies S.A. - Spons-ADR is N/A and the PB ratio is 5.03.